265 related articles for article (PubMed ID: 38534705)
1. Scientific Rationale and Clinical Basis for Clindamycin Use in the Treatment of Dermatologic Disease.
Armillei MK; Lomakin IB; Del Rosso JQ; Grada A; Bunick CG
Antibiotics (Basel); 2024 Mar; 13(3):. PubMed ID: 38534705
[TBL] [Abstract][Full Text] [Related]
2. Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
Lovrić I; Brkić J; Ćorluka M; Čović M; Pejić J; Zeljko Penavić J
Acta Dermatovenerol Croat; 2021 Jul; 29(2):108-110. PubMed ID: 34477078
[TBL] [Abstract][Full Text] [Related]
3. Topical clindamycin in the management of acne vulgaris.
Guay DR
Expert Opin Pharmacother; 2007 Oct; 8(15):2625-64. PubMed ID: 17931096
[TBL] [Abstract][Full Text] [Related]
4. The Antibiotic Susceptibility Profile of Cutibacterium Acnes in Maltese Patients with Acne.
Mercieca L; Mangion J; Cefai J; Bezzina T; Schwaiger C; Micallef D; Corso R; Scerri L; Boffa MJ; Caruana P; Clark E; Aquilina S
J Clin Aesthet Dermatol; 2020 Jun; 13(6):11-16. PubMed ID: 32884613
[No Abstract] [Full Text] [Related]
5. Increased frequency of clindamycin-resistant Cutibacterium acnes strains isolated from Japanese patients with acne vulgaris caused by the prevalence of exogenous resistance genes.
Koyanagi S; Koizumi J; Nakase K; Hayashi N; Horiuchi Y; Watanabe K; Asai T; Yamazaki A; Nakazaki E; Nakaminami H
J Dermatol; 2023 Jun; 50(6):793-799. PubMed ID: 36880295
[TBL] [Abstract][Full Text] [Related]
6. [Phylotyping and Determining the Antimicrobial Susceptibility of Cutibacterium acnes Isolated from Patients with Acne Vulgaris].
Özel Kaya N; Usta İ; Demirçay ZÖ; Ülger Toprak N
Mikrobiyol Bul; 2021 Oct; 55(4):465-479. PubMed ID: 34666649
[TBL] [Abstract][Full Text] [Related]
7. Characterization of acne patients carrying clindamycin-resistant Cutibacterium acnes: A Japanese multicenter study.
Nakase K; Aoki S; Sei S; Fukumoto S; Horiuchi Y; Yasuda T; Tanioka M; Sugai J; Huh WW; Kakuta M; Nomoto M; Shimada T; Watanabe M; Kobayashi M; Murakami S; Takeo C; Tsubouchi R; Hayashi N; Noguchi N
J Dermatol; 2020 Aug; 47(8):863-869. PubMed ID: 32424832
[TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind comparison of a clindamycin phosphate/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris.
Cunliffe WJ; Holland KT; Bojar R; Levy SF
Clin Ther; 2002 Jul; 24(7):1117-33. PubMed ID: 12182256
[TBL] [Abstract][Full Text] [Related]
9. Association of Antimicrobial Susceptibility and Treatment Outcome in Acne Vulgaris Patients: A Pilot Study.
Yadav AK; Bhooshan S; Johnson A; Asati DP; Nema S; Biswas D
J Lab Physicians; 2020 Dec; 12(4):233-238. PubMed ID: 33469248
[No Abstract] [Full Text] [Related]
10. PEG-8 Laurate Fermentation of
Marito S; Keshari S; Huang CM
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32707723
[TBL] [Abstract][Full Text] [Related]
11. Multidrug Resistance Plasmid pTZC1 Could Be Pooled among
Koizumi J; Nakase K; Hayashi N; Takeo C; Nakaminami H
Microbiol Spectr; 2023 Feb; 11(2):e0362822. PubMed ID: 36847559
[TBL] [Abstract][Full Text] [Related]
12. Sarecycline Demonstrates Clinical Effectiveness against Staphylococcal Infections and Inflammatory Dermatoses: Evidence for Improving Antibiotic Stewardship in Dermatology.
Grada A; Ghannoum MA; Bunick CG
Antibiotics (Basel); 2022 May; 11(6):. PubMed ID: 35740129
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of VB-1953 Topical Gel in Non-Responder Acne Patients with Clindamycin-Resistant Cutibacterium acnes.
Batra R; Sadhasivam S; Saini S; Gupta S; Bisen RKS; Sinha M; Ghosh S; Jain S
Drugs R D; 2020 Jun; 20(2):95-104. PubMed ID: 32222937
[TBL] [Abstract][Full Text] [Related]
14. Comparative Trial of Silver Nanoparticle Gel and 1% Clindamycin Gel when Use in Combination with 2.5% Benzoyl Peroxide in Patients with Moderate Acne Vulgaris.
Jurairattanaporn N; Chalermchai T; Ophaswongse S; Udompataikul M
J Med Assoc Thai; 2017 Jan; 100(1):78-85. PubMed ID: 29911775
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of Biofilm-Forming Ability and Antibiotic Resistance of
Ruchiatan K; Rizqandaru T; Satjamanggala PR; Tache N; Cahyadi AI; Rezano A; Gunawan H; Sutedja EK; Dwiyana RF; Hidayah RMN; Achdiat PA; Sutedja E; Suwarsa O; Hindritiani R
Clin Cosmet Investig Dermatol; 2023; 16():2457-2465. PubMed ID: 37719934
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic resistant Cutibacterium acnes among acne patients in Jordan: a cross sectional study.
Alkhawaja E; Hammadi S; Abdelmalek M; Mahasneh N; Alkhawaja B; Abdelmalek SM
BMC Dermatol; 2020 Nov; 20(1):17. PubMed ID: 33203374
[TBL] [Abstract][Full Text] [Related]
17. Antibiotics and Antimicrobial Resistance in Acne: Epidemiological Trends and Clinical Practice Considerations.
Dessinioti C; Katsambas A
Yale J Biol Med; 2022 Dec; 95(4):429-443. PubMed ID: 36568833
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic susceptibility of Propionibacterium acnes isolated from acne vulgaris in Korea.
Song M; Seo SH; Ko HC; Oh CK; Kwon KS; Chang CL; Kim MB
J Dermatol; 2011 Jul; 38(7):667-73. PubMed ID: 21352337
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic Resistance Risk with Oral Tetracycline Treatment of Acne Vulgaris.
Swallow MA; Fan R; Cohen JM; Bunick CG
Antibiotics (Basel); 2022 Jul; 11(8):. PubMed ID: 36009899
[TBL] [Abstract][Full Text] [Related]
20. A cross-sectional study examining the prevalence of antibiotic-resistant Cutibacterium acnes isolated from patients with acne in Bangkok, Thailand.
Sermswan P; Sriharat R; Saithong S; Laowansiri M; Amornruk N; Chiewchengchol D; Noppakun N; Asawanonda P; Chatsuwan T; Kumtornrut C
J Dermatol; 2023 Aug; 50(8):1008-1013. PubMed ID: 37183535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
